Adcock Ingram delisting from the JSE is confirmed for November 11. Learn about the impact of the Natco Pharma acquisition.
Adcock Ingram Delisting After Natco Acquisition
Original Article by Jacqueline Mackenzie | Business Day | 27 October 2025
Adcock Ingram delisting from the JSE is confirmed for November 11. Learn about the impact of the Natco Pharma acquisition.
More Posts
Mpox Cases in SA Rise as Local Transmission Accelerates
Mpox cases in South Africa are rising, mainly in the Western Cape. What the surge means for the healthcare industry.
Read more...
NHLS Scrambles as Pathology Services Funding Runs Dry
The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt
Read more...
Momentum Group Posts Record Earnings
Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.
Read more...